TYK Medicines, Inc. Class H(HK:2410)
HK$4.10+0.23 (+5.94%)
HK:2410
TYK Medicines, Inc. Class H financials statements
HK$4.10
At close:+0.23 (+5.94%)
Want to see HK:2410 full AI Analyst Report?
TYK Medicines, Inc. Class H (2410) Financial Statements
2 Followers
TYK Medicines, Inc. Class H Financial Overview
TYK Medicines, Inc. Class H's market cap is currently ¥1.47B. The company's EPS TTM is ¥-0.56; its P/E ratio is -6.21; TYK Medicines, Inc. Class H has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | |
|---|---|---|---|---|
| Income Statement | ||||
| Total Revenue | ¥ 0.00 | ¥ 107.00K | ¥ 0.00 | ¥ 44.24M |
| Gross Profit | ¥ -24.37M | ¥ 14.00K | ¥ -27.66M | ¥ 20.04M |
| Operating Income | ¥ -314.19M | ¥ -316.80M | ¥ -306.84M | ¥ -234.79M |
| EBITDA | ¥ -289.17M | ¥ -346.03M | ¥ -346.80M | ¥ -292.22M |
| Net Income | ¥ -292.01M | ¥ -386.95M | ¥ -382.43M | ¥ -310.99M |
| Balance Sheet | ||||
| Cash & Short-Term Investments | ¥ 367.44M | ¥ 460.46M | ¥ 192.83M | ¥ 243.49M |
| Total Assets | ¥ 780.07M | ¥ 915.69M | ¥ 573.14M | ¥ 558.36M |
| Total Debt | ¥ 152.81M | ¥ 176.85M | ¥ 1.33B | ¥ 82.33M |
| Net Debt | ¥ -214.63M | ¥ -258.62M | ¥ 1.14B | ¥ -8.44M |
| Total Liabilities | ¥ 493.13M | ¥ 443.13M | ¥ 1.45B | ¥ 1.06B |
| Stockholders' Equity | ¥ 286.79M | ¥ 469.09M | ¥ -884.48M | ¥ -505.94M |
| Cash Flow | ||||
| Free Cash Flow | ¥ -255.18M | ¥ -381.87M | ¥ -278.20M | ¥ -308.23M |
| Operating Cash Flow | ¥ -215.77M | ¥ -308.25M | ¥ -200.94M | ¥ -220.05M |
| Investing Cash Flow | ¥ 35.95M | ¥ -135.86M | ¥ 73.01M | ¥ -158.16M |
| Financing Cash Flow | ¥ 126.38M | ¥ 632.08M | ¥ 224.00M | ¥ 351.14M |
Currency in CNY
